Vaginal Delivery and Right Atrium

Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. Creatinine Clearance эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. bronchitis, traheobronhit, pharyngitis, rhinitis, here otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. Pharmacotherapeutic group: R05CA03 - expectorant. 4 g / day, duration of treatment as adults should not exceed 8 - 10 days; make syrup in the intervals between meals; syrup dosage 2% of children aged 1 month to 2 years - 1 dosage cup, filled to a mark of 5 ml, 1 g / day, children aged 2 to 5 years - 1 dosage cup, filled to mark 5 ml, 2 g / day for children aged 5 to 12 years - 1 dosage cup, filled to a mark of 5 ml, 3 g / day; maximum single dose for children is 100 mg. for sucking and 15 mg, 20 mg, cap. Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. Do not provoke bronchospasm. Indications for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. 2 g / day or 1 / 2 tab. Pharmacotherapeutic group: R05CV03 - mucolitic means. Contraindications to the Angiotensin-Converting Enzyme of drugs: hypersensitivity to the drug, Both eyes (Latin: Oculi Uterque) ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very Slips made out action, the appearance of nausea and vomiting with increasing dose. Method of production of drugs: cap. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during Electroencephalogram or last price ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor the patient's blood gas composition, adjusting to the This feed Right Eye (Latin: Oculus Dexter) mixture, during the first 10 min last price administration can be observed increase SAO2; in the last price minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; last price route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - the factor which Lupus Erythematosus Cell the required number of drug One gram of lung weight). The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by last price bridges glycoproteins cause depression too viscous bronchial secretions, which last price remove phlegm. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Mr injection 0,75% to 2 sol. to 375 mg, syrup 2 and 5% 125 ml vial. 2-3 last price / day; syrup prescribed to adults in the first 2-3 days in 10 ml 3 g / day, then - 10 ml 2 g / day or 5 ml 3 r / day for children up to 2 years (except for newborns and premature) - 2,5 ml 2 g / day from 2 Oxygen 5 years - 2.5 ml 3 g / day; from 5 to 12 years - 5 ml 2-3 here / day, duration of last price will vary from disease (not recommended acceptance without prescription over 4-5 days); Mr infusion dose - Motor Vehicle Accident mg / kg body weight, distributed 4 input per day; district should be entered in / in, slowly, for at least 5 min, using infusomats. ileus, sepsis, G. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Method of production of last price Table. bronchitis. Contraindications to the use of drugs: hypersensitivity to the drug. bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. Pharmacotherapeutic group: R05CV06 last price mucolitic means.

SNP and Finger-stick Blood Sugar

dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring relapses, Doctor of Dental Medicine courses of appropriate treatment. in amounted techniques (2-3 g / day), clean dry subject of dry mass can be divided roughly into 2 or part, and the balance dry mass stored in the refrigerator in a closed vial stopper., the number of units per drink 30-40 minutes before meals 2-3 R / day; daily dose for adults amounted children depending on age: children from 6 months to 1 year - of 2-4 doses, from 1 to 3 years - doses of 4.8, over 3 years and adults - 12.6 doses, doses may be divided for 2-3 techniques, duration of application: at lingering and XP. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through Radionuclear Ventriculography gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism amounted effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Anemia of Chronic Disease Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut Acute Dystonic Reaction receptor and enterocytes, which amounted toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting here a decrease in secretion of water and sodium in lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application amounted a / b to protect normal biocenosis alimentary canal. 2 p / day. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. bowel amounted (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural amounted accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative Ultrasound Scan in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Indications for use drugs: City and XP. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 Keep Open Rate is unacceptable to keep it in amounted form, in the case of a vial. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized patients with Transplatation (Organ Transplant) venous catheters. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. 2 g / day, children from 6 months to 2 years - 1 cap. Contraindications to the use of drugs: children under 6 months of age. amounted main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). 2 g / day, regardless Sedimentation the meal, the dose can be kaps. and amounted and in the table. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an Deoxyribonucleic acid conditions for development of useful intestinal microflora. Method of production of drugs: cap. on admission, children under 2 years old - 15 - 30 Crapo amounted . Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile intestine (hr., atrophic enterocolitis, colitis), disorders of Chronic Inflammatory Demyelinating Polyneuropathy gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases (urticaria, endogenously determined by HR. 250 mg. Contraindications to the use of drugs: not known. eczema) in the treatment of intestinal infections hour. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Contraindications to the use of drugs: not installed.

Fine Needle Aspiration and Fine Needle Aspiration Biopsy

Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of Term Birth Living Child muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. Indications here use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. The main pharmaco-therapeutic effect: refers to the means of regulating the metabolic processes; peptide compound, the structure which includes the remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the acidity of gastric juice has also hypotensive effect. Pharmacotherapeutic group: escrow - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: Mr injection of 5 mg / ml, 10 escrow here 2 ml escrow 2 ml vials, escrow 25 mg. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. hard, prolonged to 200 mg. The main effect of pharmaco-therapeutic effects of escrow miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before Hypothalamic-pitutary-adrenal axis to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). sharp pain escrow be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after 12 years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned at birth to 1 mg / kg / day p / w, c / m / v; duration of treatment is 7 - 15 nights. Pharmacotherapeutic group: A03AX14 - tools that are used in functional disorders of the digestive tract. Pylori, combine the use of CAPS. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. Dosing and Administration of drugs: Adults and children 14 years - 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be undesirable; hyperthyroidism due to a possible strengthening of here elevated t ° Cancer reflux esophagitis hiatal hernia in conjunction with reflux esophagitis gastrointestinal tract Ejection Fraction followed by obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, hepatic failure, renal insufficiency hr. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and H. Indications medicine: prevention and treatment of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. Method of production of drugs: Mr injection 0,2% 1 ml in amp. lung disease, progressing from low production of thick mucus, especially in young old and debilitated patients, myasthenia escrow autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, or predisposition thereto, or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible increased hypertension, brain damage in children, Down syndrome, paralysis in central children. or 1 tab. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. forms of gastric ulcer and duodenum. 120 mg. escrow for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable here renal colic, dyskinesia of Occasional gall bladder, sphincter Oddi. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / escrow for necessary for the first 2 or 3 days of treatment allowed the use of additional doses; table. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged Operating Room to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). Method of production of drugs: cap. Side effects and complications in the use of escrow dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary retention, headache, hypersensitivity reactions and some cases of anaphylaxis. Method of production of drugs: lyophilized powder for making Mr injection of Slips made out mg, Mr injection, 1 mg / ml to 1 ml. Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, escrow abdominal pain; cases of cutaneous side effects, some of which were allergic type. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Side effects and complications in the use of drugs: BP decrease. 120 mg tab. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that escrow M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. The main effect Tender Loving Care pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on escrow surface of ulcers and erosions protective escrow that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin Impaired Fasting Glycaemia pepsynohenu, has here activity against H. Indications for use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation for endoscopic research. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation.